HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gil I Wolfe Selected Research

Thymectomy

11/2020Minimal manifestation status and prednisone withdrawal in the MGTX trial.
1/2020Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study.
5/2019A Neurologist's Perspective on Thymectomy for Myasthenia Gravis: Current Perspective and Future Trials.
1/2019Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.
1/2018Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution.
12/2016Randomized trial of thymectomy in myasthenia gravis.
11/2016Randomized Trial of Thymectomy in Myasthenia Gravis.
11/2016Randomized Trial of Thymectomy in Myasthenia Gravis.
6/2016What's in the Literature?
7/2012Myasthenia gravis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gil I Wolfe Research Topics

Disease

32Myasthenia Gravis
12/2021 - 10/2002
4Neuralgia (Stump Neuralgia)
05/2013 - 12/2002
3Thymoma (Thymic Carcinoma)
11/2020 - 09/2003
3Pain (Aches)
05/2013 - 05/2003
2Fatigue
03/2021 - 02/2013
2Polyneuropathies (Polyneuropathy)
01/2018 - 09/2003
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2016 - 09/2005
2Myositis (Idiopathic Inflammatory Myopathies)
06/2016 - 10/2010
2Muscular Dystrophies (Muscular Dystrophy)
10/2010 - 05/2008
2Peripheral Nervous System Diseases (PNS Diseases)
02/2007 - 05/2003
1Muscle Weakness
11/2021
1Autoimmune Diseases (Autoimmune Disease)
11/2021
1Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
01/2020
1Inclusion Body Myositis
09/2016
1Muscle Cramp (Cramp)
09/2016
1T-Cell Leukemia (Leukemia, T Cell)
09/2016
1Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)
06/2016
1Motor Neuron Disease (Primary Lateral Sclerosis)
06/2016
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
06/2016
1Posterior Leukoencephalopathy Syndrome
03/2015
1Diarrhea
02/2013
1Dizziness (Lightheadedness)
02/2013
1Glycogen Storage Disease Type II (Pompe's Disease)
03/2012
1Guillain-Barre Syndrome
04/2011
1Neuromuscular Diseases (Neuromuscular Disease)
10/2010
1Muscular Diseases (Myopathy)
09/2010
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
05/2008
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
05/2008
1Hypersensitivity (Allergy)
05/2008
1Stroke (Strokes)
01/2008
1Nervous System Diseases (Neurological Disorders)
01/2008
1Pernicious Anemia
01/2008
1Neoplasms (Cancer)
02/2007
1Hemangioblastoma
12/2005
1Hemangioma (Angioma)
12/2005
1Renal Cell Carcinoma (Grawitz Tumor)
12/2005
1Fasciculation (Fasciculations)
09/2005
1Hypesthesia (Numbness)
05/2003

Drug/Important Bio-Agent (IBA)

10Cholinergic ReceptorsIBA
12/2021 - 04/2006
10Prednisone (Sone)FDA LinkGeneric
01/2021 - 01/2008
6AntibodiesIBA
05/2019 - 04/2006
5margatoxinIBA
11/2020 - 01/2008
4glucose-mannose-glucoseIBA
11/2021 - 01/2020
4muskIBA
03/2010 - 04/2006
3Rituximab (Mabthera)FDA Link
12/2021 - 01/2017
3AutoantibodiesIBA
11/2021 - 02/2007
3Intravenous Immunoglobulins (IVIG)FDA Link
01/2020 - 10/2002
3Biomarkers (Surrogate Marker)IBA
06/2016 - 01/2008
3Anticonvulsants (Antiepileptic Drugs)IBA
05/2013 - 12/2002
3Antidepressive Agents (Antidepressants)IBA
05/2013 - 12/2002
2Immunoglobulins (Immunoglobulin)IBA
03/2021 - 01/2020
2Pharmaceutical PreparationsIBA
01/2020 - 01/2020
2Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2019 - 01/2009
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019 - 03/2010
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
05/2015 - 11/2008
2Phosphotransferases (Kinase)IBA
12/2012 - 03/2010
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2009 - 01/2008
2Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
01/2008 - 09/2003
1Immunoglobulin G (IgG)IBA
11/2021
1Lipoproteins (Lipoprotein)IBA
03/2021
1AgrinIBA
03/2021
1eculizumabFDA Link
01/2021
1Complement Inactivating AgentsIBA
01/2020
1zilucoplanIBA
01/2020
1Edrophonium (Tensilon)FDA LinkGeneric
01/2019
1Mexiletine (Mexitil)FDA LinkGeneric
09/2016
1Valosin Containing ProteinIBA
09/2016
1Antisense OligonucleotidesIBA
06/2016
1Signal Recognition ParticleIBA
06/2016
1Oxidoreductases (Dehydrogenase)IBA
06/2016
1Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric
03/2016
1Cholinergic Agents (Cholinergics)IBA
02/2013
1alpha-Glucosidases (Acid Maltase)IBA
03/2012
1AcidsIBA
03/2012
1EnzymesIBA
03/2012
1GlycogenIBA
03/2012
1CytokinesIBA
04/2011
1Vitamin EFDA LinkGeneric
10/2010
1Neutralizing AntibodiesIBA
05/2008
1MyostatinIBA
05/2008
1StamulumabIBA
05/2008
1Nitrous Oxide (Laughing Gas)IBA
01/2008
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2006
1Retinaldehyde (Retinal)IBA
12/2005
1polyglucosanIBA
05/2003
1salicylhydroxamic acid (SHAM)IBA
05/2003
1Levodopa (L Dopa)FDA LinkGeneric
05/2003

Therapy/Procedure

14Thymectomy
11/2020 - 09/2003
10Therapeutics
03/2021 - 05/2003
3Activities of Daily Living (ADL)
11/2021 - 11/2011
3Polypharmacy
05/2013 - 12/2002
2Immunotherapy
10/2010 - 09/2010
2Drug Therapy (Chemotherapy)
10/2010 - 12/2002
1Ambulatory Care (Outpatient Care)
01/2018
1Blood Transfusion (Blood Transfusions)
03/2015
1Enzyme Replacement Therapy
03/2012
1Plasma Exchange
03/2010
1Immunomodulation
01/2009
1Denervation
09/2005
1Magnetic Field Therapy
05/2003